People with Alzheimer's disease who use antipsychotic medications have a 29% higher risk of head injury, and a 22% increased risk of TBI compared to those with the neurodegenerative disease who do not use the medications.
A new study reveals some drug combinations may be more beneficial for those with schizophrenia. Researchers found people with schizophrenia who took antidepressants, in combination with other medications, were less likely to be hospitalized for mental health issues than those who started another antipsychotic.
According to researchers, Cannabidiol, an active compound in cannabis plants, could help to alleviate cognitive impairment in people with schizophrenia.
According to researchers, a mutation in a gene associated with brain development may dispose people to various psychiatric illnesses as it reduces synapse numbers. Lithium may help to restore some of the synapses.
Researchers report a blockade of D2 receptors in interneurons can increase acetylcholine signaling above threshold on neighboring neurons, resulting in motor abnormalities.
A new study reports people with treatment resistant schizophrenia appear to have better outcomes when they are switched to clozapine rather than other antipsychotic medications.
A new study reports people with Alzheimer's disease are more likely to use antipsychotic medications, and for longer periods of time, than the general public.
According to a new study, lithium appears to be safe and effective in treating bipolar disorder in children, at least in the short term.
According to a new study, antipsychotic medications could increase the risk of death in patients with Parkinson's disease psychosis.
A new study reports many people with intellectual disabilities are being prescribed antipsychotic medications even though they have no record of mental illness.